Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High-Dose vs Standard-Dose Influenza Vaccine in Rheumatoid Arthritis
NCT02936180Phase 4Completed
- Sponsor
- McGill University Health Centre
- Start
- Oct 2016
- Primary completion
- Jul 2018
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 4 trial of influenza virus vaccine, split virion in influenza, sponsored by McGill University Health Centre. Started Oct 2016; status: completed.
02
Drugs
influenza virus vaccine, split virion
03
Conditions
influenza
Beyond the preview
Go deeper on NCT02936180.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02936180.